This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Novartis Ag, Glaxosmithkline Intellectual Property (No.2) Limited, Glaxosmithkline LLC. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3,978 
1 out of 95 
1 out of 358 
Years Active: 2013-2016
Title: The Innovative Contributions of Douglas J DeMarini
Introduction
Douglas J DeMarini is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on novel pharmaceutical compositions that have the potential to impact therapeutic practices.
Latest Patents
Among his latest patents, DeMarini has disclosed innovative pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate. These compositions include methods of using them in therapy and processes for their preparation. His work in this area showcases his commitment to advancing medical science through innovative solutions.
Career Highlights
Throughout his career, DeMarini has worked with prominent companies such as Novartis AG and GlaxoSmithKline Intellectual Property Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in pharmaceuticals.
Collaborations
DeMarini has collaborated with talented individuals in his field, including Ngocdiep T Le and Francisco Henriquez. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful pharmaceutical solutions.
Conclusion
Douglas J DeMarini's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence therapeutic practices and showcases the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile